Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism
Author:
Affiliation:
1. Division of Nephrology, Department of Medicine, Showa University School of Medicine
Publisher
Tohoku University Medical Press
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://www.jstage.jst.go.jp/article/tjem/238/3/238_205/_pdf
Reference28 articles.
1. Agarwal, M., Csongrádi, É., Koch, C.A., Juncos, L.A., Echols, V., Tapolyai, M. & Fülöp, T. (2013) Severe symptomatic hypocalcemia after denosumab administration in an end-stage renal disease patient on peritoneal dialysis with controlled secondary hyperparathyroidism. Br. J. Med. Med. Res., 3, 1398-1406.
2. Bertoni, E., Rosati, A., Larti, A., Merciai, C., Zanazzi, M., Rosso, G., Gallo, M., Marcucci, R. & Salvadori, M. (2006) Chronic kidney disease is still present after renal transplantation with excellent function. Transplant. Proc., 38, 1024-1025.
3. Block, G.A., Bone, H.G., Fang, L., Lee, E. & Padhi, D. (2012) A single-dose study of denosumab in patients with various degrees of renal impairment. J. Bone Miner. Res., 27, 1471-1479.
4. Chen, C.L., Chen, N.C., Hsu, C.Y., Chou, K.J., Lee, P.T., Fang, H.C. & Renn, J.H. (2014) An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis. J. Clin. Endocrinol. Metab., 99, 2426-2432.
5. Chen, C.L., Chen, N.C., Liang, H.L., Hsu, C.Y., Chou, K.J., Fang, H.C. & Lee, P.T. (2015) Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass. J. Clin. Endocrinol. Metab., 100, 2784-2792.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation;Biomedicines;2022-12-22
2. Mineral and bone disorder after kidney transplantation (KTx);Brazilian Journal of Nephrology;2021
3. Off-label uses of denosumab in metabolic bone diseases;Bone;2019-12
4. Osteoporosis Therapy With Denosumab in Organ Transplant Recipients;Frontiers in Endocrinology;2018-04-17
5. Endocrine and Metabolic Emergencies in Transplantation;Endocrine and Metabolic Medical Emergencies;2018-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3